In agreement with our results,GAPDH has stable expression in the human brain, particularly the cerebellum, in patients with various neurodegenerative diseases as well as in normal control patients (Coulsonet al., 2008;Grunblattet al., 2004). This evidence concerns the gene GAPDH and neurodegenerative disease.